PX
60
-3
AVGO
40
-7
CVS
29
-7
ZION
60
-3
BMY
46
-2
LB
1
-8
EXPE
81
-7
SLB
39
-3
CNP
60
5
QRVO
13
4
MU
35
-7
HAL
39
-2
RIG
49
-5
M
42
-4
XEL
55
2
JNJ
33
-2
PEP
45
4
CME
58
2
ECL
62
5
CMCSA
41
2
PX
60
-3
AVGO
40
-7
CVS
29
-7
ZION
60
-3
BMY
46
-2
LB
1
-8
EXPE
81
-7
SLB
39
-3
CNP
60
5
QRVO
13
4
MU
35
-7
HAL
39
-2
RIG
49
-5
M
42
-4
XEL
55
2
JNJ
33
-2
PEP
45
4
CME
58
2
ECL
62
5
CMCSA
41
2
Financhill
Back

Aldeyra Therapeutics 10K Form

Sell
40

ALDX
Aldeyra Therapeutics

Last Price:
4.91
Seasonality Move:
6.52%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive ALDX News And Ratings

See the #1 stock for the next 7 days that we like better than ALDX

ALDX Financial Statistics

Sales & Book Value

Annual Sales: $0
Cash Flow: $-7.97M
Price / Cash Flow: 0
Annual Sales: $1.43
Price / Book: 3.51

Profitability

EPS (TTM): -0.75000
Net Income (TTM): $-44.8M
Gross Margin: $0
Return on Equity: 0%
Return on Assets: 0%

Aldeyra Therapeutics Earnings Forecast

Key Aldeyra Therapeutics Financial Ratios

  • The Interest Expense is -5.52% of Operating Income.
  • Per Share Earnings over the last 13 years have been positive in 8 years.

Aldeyra Therapeutics Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Biotechnology
Sector: Health Care
Current Symbol: ALDX
CUSIP: 01438T
Website: aldeyra.com

Debt

Debt-to-Equity Ratio: 0
Current Ratio: 0
Quick Ratio: 0

Price-to-Earnings

Trailing P/E Ratio: 0
Forward P/E Ratio: 0

ALDX Technical Analysis vs Fundamental Analysis

Sell
40
Aldeyra Therapeutics (ALDX) is a Sell

Is Aldeyra Therapeutics a Buy or a Sell?